Level 2 · Controlled trialRandomised controlled trial

Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide

Somekawa Y, Chigughi M, Harada M, Ishibashi T

The Journal of clinical endocrinology and metabolism · 1 August 1999

AUTHORS’ ABSTRACT

The abstract of this article is not reproduced here: its licence does not allow it. It can be read freely on the journal’s website or on Europe PMC.

Scientific information content; it does not replace the advice of a healthcare professional. The presence of a study in this library does not constitute a claim about our products.

← All studies